Ghost Tree Capital as of Dec. 31, 2015
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 47 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NuVasive | 5.1 | $12M | 230k | 54.11 | |
| Amgen (AMGN) | 5.0 | $12M | 75k | 162.33 | |
| Wright Medical Group Nv | 5.0 | $12M | 500k | 24.18 | |
| Portola Pharmaceuticals | 4.8 | $12M | 230k | 51.45 | |
| Sage Therapeutics (SAGE) | 4.8 | $12M | 200k | 58.30 | |
| Seattle Genetics | 4.1 | $10M | 225k | 44.88 | |
| Mallinckrodt Pub | 4.1 | $10M | 135k | 74.63 | |
| Pacific Biosciences of California (PACB) | 4.0 | $9.8M | 750k | 13.13 | |
| ACADIA Pharmaceuticals (ACAD) | 3.6 | $8.9M | 250k | 35.65 | |
| Integra LifeSciences Holdings (IART) | 3.3 | $8.1M | 120k | 67.78 | |
| Mirati Therapeutics | 3.2 | $7.9M | 250k | 31.60 | |
| Zeltiq Aesthetics | 3.2 | $7.8M | 275k | 28.53 | |
| Bluebird Bio (BLUE) | 3.2 | $7.7M | 120k | 64.22 | |
| Biogen Idec (BIIB) | 3.1 | $7.7M | 25k | 306.36 | |
| Spectranetics Corporation | 2.7 | $6.6M | 435k | 15.06 | |
| Achillion Pharmaceuticals | 2.6 | $6.5M | 600k | 10.79 | |
| Prothena (PRTA) | 2.5 | $6.1M | 90k | 68.11 | |
| Nanostring Technologies (NSTGQ) | 2.4 | $5.9M | 400k | 14.71 | |
| Nevro (NVRO) | 2.4 | $5.7M | 85k | 67.51 | |
| Incyte Corporation (INCY) | 2.2 | $5.4M | 50k | 108.46 | |
| Dbv Technologies S A (DBVT) | 2.2 | $5.3M | 80k | 66.42 | |
| Vitae Pharmaceuticals | 2.0 | $5.0M | 275k | 18.10 | |
| Acorda Therapeutics | 1.8 | $4.3M | 100k | 42.78 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $4.2M | 45k | 94.13 | |
| Five Prime Therapeutics | 1.7 | $4.2M | 100k | 41.50 | |
| Tandem Diabetes Care | 1.7 | $4.1M | 350k | 11.81 | |
| Sarepta Therapeutics (SRPT) | 1.6 | $3.9M | 100k | 38.58 | |
| Retrophin | 1.6 | $3.9M | 200k | 19.29 | |
| Synergy Pharmaceuticals | 1.4 | $3.4M | 600k | 5.67 | |
| GenMark Diagnostics | 1.3 | $3.2M | 410k | 7.76 | |
| Alcobra | 1.3 | $3.1M | 500k | 6.28 | |
| Tonix Pharmaceuticls | 1.1 | $2.7M | 350k | 7.67 | |
| Entellus Medical Cm | 1.0 | $2.5M | 150k | 16.86 | |
| Adaptimmune Therapeutics (ADAP) | 1.0 | $2.5M | 210k | 12.06 | |
| Veracyte (VCYT) | 1.0 | $2.5M | 350k | 7.20 | |
| Cynapsus Therapeutics | 0.9 | $2.3M | 152k | 15.29 | |
| Pacira Pharmaceuticals (PCRX) | 0.9 | $2.3M | 30k | 76.80 | |
| Clovis Oncology | 0.7 | $1.8M | 50k | 35.00 | |
| D Fluidigm Corp Del (LAB) | 0.7 | $1.6M | 150k | 10.81 | |
| Dynavax Technologies (DVAX) | 0.5 | $1.3M | 55k | 24.16 | |
| Corium Intl | 0.4 | $1.0M | 125k | 8.12 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $996k | 60k | 16.60 | |
| Amicus Therapeutics (FOLD) | 0.4 | $970k | 100k | 9.70 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $921k | 376k | 2.45 | |
| Akari Therapeutics | 0.3 | $683k | 47k | 14.50 | |
| Strongbridge Bioph shs usd | 0.2 | $553k | 73k | 7.60 | |
| Ocera Therapeutics | 0.2 | $390k | 125k | 3.12 |
